New Two-Step transplant shows promise for tough blood cancers
NCT ID NCT03032783
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase 2 trial tested a two-step donor stem cell transplant in 51 people with high-risk blood cancers. The approach uses total-body irradiation and chemotherapy to prepare the body, then infuses donor stem cells and later donor immune cells. The goal is to boost the anti-cancer effect while limiting severe side effects. The study looked at overall survival at two years and rates of graft failure and early death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- donor stem cells (with total-body irradiation, donor lymphocyte infusion, and cyclophosphamide)
- What this could lead to
- If successful, this approach could offer a safer way to perform donor stem cell transplants for people with high-risk blood cancers, potentially improving survival rates.
- What could go wrong
- This is a completed phase 2 trial with only 51 participants, so results are preliminary. The treatment carries risks like graft failure, severe infection, and organ damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Philadephia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer reveal hidden immune clues in tumors?
- A hug in a blanket: could deep pressure calm cancer infusion anxiety?
- Could a strong social circle turn back the clock for transplant survivors?
- Can a Two-Step stem cell transplant tame Graft-Versus-Host disease?
- Lab-Grown stem cells could speed immune recovery in blood cancer transplants
- Detroit study tests video to boost cancer trial interest